Skeletal muscle and cardiovascular diseases continue to pose significant challenges to public health, affecting a wide range ...
Morning Overview on MSN
New breakthrough could shield global food supply from a massive threat
Climate change is steadily eroding the foundations of the global food system, from heat‑stressed rice paddies to drought‑stricken wheat fields. At the same time, surging demand and degrading soils are ...
Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. | Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. GSK has decided not ...
Wave claimed GSK is handing back rights to the frontrunning program not because of questions about its potential, but because ...
Civitai—an online marketplace for buying and selling AI-generated content, backed by the venture capital firm Andreessen Horowitz—is letting users buy custom instruction files for generating celebrity ...
Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...
Morning Overview on MSN
Google DeepMind AI lights up the dark genome and flags risky DNA tweaks
Google DeepMind’s latest artificial intelligence model is turning the most mysterious stretches of human DNA into readable text, and in the process, it is flagging which tiny edits could tip a cell ...
Global Mice Model Market OverviewThe global mice model market is projected to grow at an approximate rate of 9% over the next five years, supported by increasing demand for personalized medicine, ...
GreenWood Investors reported 52.5% net returns in 2025, significantly outperforming the MSCI ACWI index. Read the full letter ...
The potentially $1 billion alliance centered around a flexible gene editing technology adds to a portfolio of cutting-edge ...
Pneumocystis is an unwieldy genus of fungal pathogens that cause severe pneumonia, particularly in immunocompromised people like those with HIV/AIDs or who have received organ transplants. However, ...
Eli Lilly (NYSE: LLY) announced a global research collaboration with Seamless Therapeutics to develop programmable gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results